AAAAAA
Results: 1-25/29
Authors:
BERTRAND E
CHARTRAND P
SCHAEFER M
SHENOY SM
SINGER RH
LONG RM
Citation: E. Bertrand et al., LOCALIZATION OF ASH1 MESSENGER-RNA PARTICLES IN LIVING YEAST, MOLECULAR CELL, 2(4), 1998, pp. 437-445
Authors:
LONG RM
BERTRAND E
CHARTRAND P
SCHAEFER M
SHENOY S
SINGER RH
Citation: Rm. Long et al., TRANSPORT AND LOCALIZATION OF A ASH1 MESSENGER-RNA DEPENDENT GFP PARTICLE IN LIVING YEAST, Molecular biology of the cell, 9, 1998, pp. 1094-1094
Authors:
CHARTRAND P
MENG X
SINGER RH
LONG RM
Citation: P. Chartrand et al., IDENTIFICATION AND CHARACTERIZATION OF 3 CIS-ACTING ELEMENTS INVOLVEDIN THE LOCALIZATION OF THE ASH1 MESSENGER-RNA IN YEAST, Molecular biology of the cell, 9, 1998, pp. 1095-1095
Authors:
LONG RM
Citation: Rm. Long, PART I - WHAT IS THE SCOPE OF INSTITUTIONAL TRAINING-PROGRAMS (T32S) SUPPORTED BY THE NIGMS - WHERE IS MORE INFORMATION AVAILABLE, Pharmaceutical research, 15(8), 1998, pp. 1149-1151
Authors:
LONG RM
Citation: Rm. Long, NEWS FROM THE NATIONAL-INSTITUTE-OF-GENERAL-MEDICAL-SCIENCES (NIGMS), Pharmaceutical research, 15(4), 1998, pp. 513-514
Authors:
LONG RM
Citation: Rm. Long, NEWS FROM THE NATIONAL-INSTITUTE-OF-GENERAL-MEDICAL-SCIENCES (NIGMS), Pharmaceutical research, 15(2), 1998, pp. 165-166
Authors:
LONG RM
Citation: Rm. Long, PART II - WHAT DO REVIEWERS CONSIDER WHEN EVALUATING INSTITUTIONAL RESEARCH TRAINING-PROGRAM GRANT APPLICATIONS (T32S) TO THE NIGMS, Pharmaceutical research, 15(11), 1998, pp. 1647-1648
Authors:
LONG RM
CHARTRAND P
GU W
MENG XH
SCHAEFER MR
SINGER RH
Citation: Rm. Long et al., CHARACTERIZATION OF TRANSPORT AND LOCALIZATION OF ASH1 MESSENGER-RNA IN YEAST, Molecular biology of the cell, 8, 1997, pp. 2060-2060
Authors:
LONG RM
Citation: Rm. Long, WHAT ARE THE HIGH-RISK HIGH-IMPACT (R21) AWARDS SUPPORTED BY THE NIGMS - WHERE IS INFORMATION AVAILABLE ABOUT THIS NEW PROGRAM, Pharmaceutical research, 14(9), 1997, pp. 1103-1103
Authors:
LONG RM
Citation: Rm. Long, HOW DOES THE NIGMS SUPPORT PROGRAM PROJECT GRANTS - WHERE IS CURRENT INFORMATION AVAILABLE ABOUT THIS MECHANISM, Pharmaceutical research, 14(7), 1997, pp. 839-839
Authors:
LONG RM
Citation: Rm. Long, WHAT CAN NIH GRANTEES DO TO INCREASE THE PUBLICS UNDERSTANDING OF THEINSTITUTES ROLES IN SUPPORTING BIOMEDICAL-RESEARCH, Pharmaceutical research, 14(5), 1997, pp. 553-553
Authors:
LONG RM
Citation: Rm. Long, WHAT IS THE RECENT HISTORY OF NIH GRANTS AWARDED TO FEMALE SCIENTISTS, Pharmaceutical research, 14(4), 1997, pp. 371-371
Authors:
LONG RM
Citation: Rm. Long, HOW CAN I GET INFORMATION ABOUT RESEARCH PROJECTS FUNDED BY THE NIH IN MY SCIENTIFIC AREA, Pharmaceutical research, 14(11), 1997, pp. 1499-1499
Authors:
LONG RM
Citation: Rm. Long, WHAT IS THE NIGMS DOING TO HELP SMOOTH OUT THE IRREGULARITIES IN FUNDING FOR ONGOING RESEARCH PROGRAMS THAT ALMOST INEVITABLY OCCUR OVER TIME IN TODAYS FISCAL CLIMATE, Pharmaceutical research, 14(1), 1997, pp. 1-1
Authors:
LONG RM
SINGER RH
MENG XH
GONZALEZ I
NASMYTH K
JANSEN RP
Citation: Rm. Long et al., MATING-TYPE SWITCHING IN YEAST CONTROLLED BY ASYMMETRIC LOCALIZATION OF ASH1 MESSENGER-RNA, Science, 277(5324), 1997, pp. 383-387
Authors:
LONG RM
JANSEN RP
GONZALES I
NASMYTH K
SINGER RH
Citation: Rm. Long et al., ASYMMETRIC LOCALIZATION OF ASH1 MESSENGER-RNA IN SACCHAROMYCES-CEREVISIAE AS DETERMINED BY FLUORESCENT IN-SITU HYBRIDIZATION, Molecular biology of the cell, 7, 1996, pp. 603-603
Authors:
LONG RM
Citation: Rm. Long, NIGMS PROGRAM ANNOUNCEMENT - FACTORS THAT DETERMINE THERAPEUTIC DRUG BIOAVAILABILITY, PA-95-001, The FASEB journal, 10(3), 1996, pp. 488-488
Authors:
LONG RM
Citation: Rm. Long, NEWS FROM THE NATIONAL-INSTITUTE-OF-GENERAL-MEDICAL-SCIENCES (NIGMS), Pharmaceutical research, 13(9), 1996, pp. 1279-1279
Authors:
LONG RM
Citation: Rm. Long, WHAT ARE REINVENTION ACTIVITIES - HOW IS THE NIH PARTICIPATING - WHATCHANGES CAN BE EXPECTED AT THE NIH - HOW CAN I GET CURRENT INFORMATION, Pharmaceutical research, 13(6), 1996, pp. 813-814
Authors:
LONG RM
Citation: Rm. Long, WHAT ARE THE DIFFERENCES BETWEEN A REQUEST FOR APPLICATION (RFA) AND A PROGRAM ANNOUNCEMENT (PA) - WHAT ARE THE ADVANTAGES AND DISADVANTAGES OF EACH, Pharmaceutical research, 13(2), 1996, pp. 185-185
Authors:
LONG RM
Citation: Rm. Long, WHAT RESEARCH TRAINING OPPORTUNITIES ARE SPONSORED BY NIGMS AT THE NIH - HOW CAN I GET INFORMATION ABOUT THIS AND OTHER POSTDOCTORAL PROGRAMS AT THE NIH, Pharmaceutical research, 13(11), 1996, pp. 1589-1589
Authors:
LONG RM
Citation: Rm. Long, NEWS FROM THE NATIONAL-INSTITUTE-OF-GENERAL-MEDICAL-SCIENCES (NIGMS), Pharmaceutical research, 13(10), 1996, pp. 1425-1426
Authors:
LONG RM
ELLIOTT DJ
STUTZ F
ROSBASH M
SINGER RH
Citation: Rm. Long et al., SPATIAL CONSEQUENCES OF DEFECTIVE PROCESSING OF SPECIFIC YEAST MESSENGER-RNAS REVEALED BY FLUORESCENT IN-SITU HYBRIDIZATION, RNA, 1(10), 1995, pp. 1071-1078
Authors:
LONG RM
ELLIOTT DJ
SHENOY S
ROSBASH M
SINGER RH
Citation: Rm. Long et al., SUBCELLULAR-LOCALIZATION OF A REPORTER TRANSCRIPT IN YEAST AS DETERMINED BY FLUORESCENCE IN-SITU HYBRIDIZATION, Molecular biology of the cell, 6, 1995, pp. 1146-1146
Authors:
LONG RM
HOPPER JE
Citation: Rm. Long et Je. Hopper, GENETIC AND CARBON SOURCE REGULATION OF PHOSPHORYLATION OF SIP1P, A SNF1P-ASSOCIATED PROTEIN INVOLVED IN CARBON RESPONSE IN SACCHAROMYCES-CEREVISIAE, Yeast, 11(3), 1995, pp. 233-246